PREP Act Extended

Amanda Applegate • December 10, 2024

Pharmacies to continue COVID-19 testing and vaccinations through 2029

The Department of Health and Human Services (HHS) has extended the Public Readiness and Emergency Preparedness (PREP) Act Declaration for Medical Countermeasures Against COVID-19 until December 31, 2029. This extension continues liability immunity for the manufacture, distribution, administration, and use of specific medical countermeasures related to COVID-19 and influenza. 


PREP Act scope:

  • Authorizes pharmacists to order and administer and authorizes interns and technicians to administer influenza and COVID-19 vaccines to patients ages 3 years and older.
  • Authorizes pharmacists to order and administer and authorizes interns and technicians to administer COVID-19 tests.
  • Provides liability immunity to covered persons against claims of loss related to the administration or use of designated medical countermeasures, except in cases of willful misconduct.


For full information, check out the Official Notice in Federal Register.


By Jen Clark May 13, 2025
Medicare Drug Price Negotiation Program changes targeted for 2028
By Jen Clark May 13, 2025
NCPA Foundation Hosts 'Redefining the Norm of Employee Pharmacy Benefits'
By Amanda Applegate May 7, 2025
Have dinner, network with peers, and learn more about KPhA!
More Posts